BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 4892857)

  • 1. Evaluation of antithymocyte serum in the treatment of canine renal homografts.
    Braf ZF; Smellie WA; Williams GM; Hume DM
    Surg Gynecol Obstet; 1969 Jul; 129(1):71-8. PubMed ID: 4892857
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of canine renal allograft survival with antilymphoid antisera.
    Shanfield I; Ladaga LG; Wren SF; Blennerhassett JB; MacLean LD
    Surg Gynecol Obstet; 1968 Jul; 127(1):29-40. PubMed ID: 4872534
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of administration of heterologous antithymus serum to New Zealand rabbits.
    Bitterman W; Shorter RG
    Exp Med Surg; 1968; 26(1-2):43-51. PubMed ID: 4180639
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of functional survival of second-set canine renal homografts using antihymocyte serum: preliminary report.
    Braf ZF; Hume DM
    Surgery; 1969 Sep; 66(3):594-6. PubMed ID: 4896077
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Horse anti-dog-lymphocyte serum].
    Dormont J; Eyquem A; Lavergne M; Bach JF; Dimitriu D; Watchi JM; Lamy R; Raynaud M
    Prog Immunobiol Stand; 1970; 4():230-8. PubMed ID: 4921387
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of specific, potent antilymphocyte serum in the horse using dog thymocytes.
    Braf ZF; Smellie WA; Williams GM; Hume DM
    Surg Forum; 1967; 18():227-9. PubMed ID: 4866923
    [No Abstract]   [Full Text] [Related]  

  • 8. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. I. Preparation of antilymphocyte serum.
    Mogi G; Harvey JE; Ohyama M; Ueda N; Ogura JH
    Laryngoscope; 1972 Jan; 82(1):61-73. PubMed ID: 4109440
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity.
    Matsukura M; Sekiguchi M; Endo S; Kurosawa T; Koishi T
    Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584
    [No Abstract]   [Full Text] [Related]  

  • 10. Antilymphocyte serum or antithymus serum.
    Nagaya H
    Arch Intern Med; 1970 Mar; 125(3):499-502. PubMed ID: 4906901
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of adult thymectomy in dogs on the immunosuppressive activity of antilymphocyte serum (ALS).
    Mogi G; Harvey JE; Ogura JH
    Laryngoscope; 1974 Jan; 84(1):78-83. PubMed ID: 4589567
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of anti-lymphocyte serum to prolong renal allograft survival in dogs.
    Fujimoto Y; Miura T; Uchida H; Inou T
    Jpn J Exp Med; 1967 Jun; 37(3):205-16. PubMed ID: 4869985
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive effect of antilymphocyte serum on the canine lung allograft as a single immunosuppressive agent.
    Iwahashi H; Nagaya H; Sealy WC; Sieker HO
    Transplantation; 1970 Jun; 9(6):558-65. PubMed ID: 4911415
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of antilymphocyte serum prepared with spleen- or thymus cells].
    Collste LG; Groth KG; Holmström B; Kashiwagi N; Lundgren G; Obel N; Schantz B; Svehag SE
    Nord Med; 1971 Jul; 86(30):919-20. PubMed ID: 4936832
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of canine renal allografts by horse anti-dog lymphocyte serum and globulin.
    Diethelm AG; Busch GJ; Dubernard JM; Orr WM; Glassock RJ; Birtch AG; Murray JE
    Ann Surg; 1969 Apr; 169(4):569-77. PubMed ID: 4886852
    [No Abstract]   [Full Text] [Related]  

  • 16. The prolongation of canine renal homograft survival by heterologous serum.
    Hinchey EJ; Bliss JQ
    Can Med Assoc J; 1966 Dec; 95(23):1169-71. PubMed ID: 5331897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Properties of heterologous immune serums against dog lymphocytes].
    Pichlmayr R; Brendel W; Tidow G
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):299-305. PubMed ID: 5591890
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of homograft immunity by antilymphocyte serum].
    Fujimoto Y
    Saishin Igaku; 1967 Sep; 22(9):1995-2006. PubMed ID: 6082213
    [No Abstract]   [Full Text] [Related]  

  • 19. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum.
    Waltman SR; Burde RM; Faulkner HW
    Transplantation; 1969 Aug; 8(2):147-51. PubMed ID: 4896328
    [No Abstract]   [Full Text] [Related]  

  • 20. Antilymphoid sera in renal allotransplantation.
    Shorter RG; Hallenbeck GA; Nava C; O'Kane H; DeWeerd JH; Johnson WJ
    Arch Surg; 1968 Aug; 97(2):323-9. PubMed ID: 4173066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.